Loading…
Rockwell Medical, Inc. is projected to rise to $0.7644 by 2027, a 0% move from its current price of $0.7641. RMTI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.7455 | $0.7644 | $0.7837 | +0.03% |
| May 30 | $0.7381 | $0.7646 | $0.7921 | +0.07% |
| May 31 | $0.7325 | $0.7649 | $0.7987 | +0.10% |
| Jun 1 | $0.7279 | $0.7651 | $0.8043 | +0.14% |
| Jun 2 | $0.7238 | $0.7654 | $0.8094 | +0.17% |
| Jun 3 | $0.7202 | $0.7657 | $0.814 | +0.21% |
| Jun 4 | $0.717 | $0.7659 | $0.8183 | +0.24% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.717 | $0.7659 | $0.8183 | +0.24% |
| Week 2 | $0.6993 | $0.7678 | $0.843 | +0.48% |
| Week 3 | $0.6864 | $0.7696 | $0.8629 | +0.72% |
| Week 4 | $0.6759 | $0.7715 | $0.8805 | +0.96% |
| Week 5 | $0.6671 | $0.7733 | $0.8964 | +1.20% |
| Week 6 | $0.6593 | $0.7752 | $0.9113 | +1.45% |
| Week 7 | $0.6524 | $0.777 | $0.9255 | +1.69% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide.
Its product line includes citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream.
The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
Rockwell Medical, Inc. currently trades at $0.7931 per share, and has a market capitalization of $31.3M. It ranks 4790 by market cap among public companies.
Forecast highlights show a near-term baseline in 2026 with an average price of $0.7931, a min of $0.78, and a max of $1.06, with an ROI of 0 and Neutral sentiment. This suggests little near-term upside relative to the current price.
Longer-term projections point to substantial upside, culminating in a 2050 average of $3.82 and a max of $6.89, with an ROI of 382.2 and bullish sentiment. The 30-day price range sits between $0.6708 and $0.9377 as a frame for the current trading context.
A major floor 16.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.5% away) — a key level to hold.
The nearest ceiling, 23.0% above — a clean break opens room to run.
A major ceiling 64.9% above — clearing it would confirm fresh momentum.
Key RMTI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RMTI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.788 | Sell | $0.7784 | Sell |
| MA 10 | $0.791 | Sell | $0.7929 | Sell |
| MA 20 | $0.8215 | Sell | $0.8171 | Sell |
| MA 50 | $0.8916 | Sell | $0.8688 | Sell |
| MA 100 | $0.9453 | Sell | $0.9228 | Sell |
| MA 200 | $1.04 | Sell | $1.04 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.23 | Neutral |
| Stoch RSI (14) | 28.89 | Neutral |
| CCI (20) | -114.53 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -8.43 | Sell |
| Bollinger %B (20,2) | 0.14 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.50 | Sell |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 37.31 | Neutral |
| Momentum (10) | -0.08 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 0.77 | Sell |
| ADX (14) | 19.37 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is Neutral, with RSI(14) at 40.
SMA(50) is $0.8984 and SMA(200) is $1.05, indicating the price has been drifting in a cautious zone relative to short- and longer-term trend lines.
Support is listed at $0.78 and resistance at $0.94, with the 30-day range spanning $0.6708 to $0.9377.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.76 | $0.7641 | $1.02 | 0% | Neutral | |
| $0.6113 | $0.7644 | $1.01 | 0% | Neutral | |
| $0.666 | $0.8536 | $1.17 | +12% | Neutral | |
| $0.7942 | $1.04 | $1.46 | +36% | Bullish | |
| $0.8136 | $1.08 | $1.55 | +42% | Bullish | |
| $0.8538 | $1.16 | $1.69 | +51% | Bullish | |
| $0.8352 | $1.15 | $1.71 | +50% | Bullish | |
| $0.8117 | $1.13 | $1.71 | +48% | Bullish | |
| $0.9032 | $1.28 | $1.96 | +67% | Bullish | |
| $0.9601 | $1.38 | $2.14 | +80% | Bullish | |
| $1.16 | $1.76 | $2.90 | +131% | Bullish | |
| $2.11 | $3.56 | $6.37 | +365% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.76 | $0.7641 | $0.8931 | +0.00% |
| June 2026 | $0.6463 | $0.7576 | $0.9081 | -0.85% |
| July 2026 | $0.6674 | $0.7883 | $0.9567 | +4.05% |
| August 2026 | $0.6755 | $0.8028 | $0.9835 | +1.84% |
| September 2026 | $0.6655 | $0.7948 | $0.9813 | -1.00% |
| October 2026 | $0.6753 | $0.8101 | $1.01 | +1.94% |
| November 2026 | $0.6895 | $0.8306 | $1.04 | +2.52% |
| December 2026 | $0.6714 | $0.8118 | $1.02 | -2.26% |
Click any year to see its month-by-month RMTI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, RMTI is projected to trade between $0.76 and $1.02, averaging $0.7641 — a potential gain of 0% from today's $0.7641. A consolidation phase looks the most probable path here.
Rockwell Medical, Inc.'s 2027 outlook centres on $0.7644, within a $0.6113 to $1.01 range. That is up 0% on the projected 2026 average. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2028, RMTI could reach as high as $1.17, with a base case around $0.8536 and support toward $0.666 — roughly +12% from $0.7641. A consolidation phase looks the most probable path here.
Expect RMTI to range from $0.7942 to $1.46 through 2029. The $1.04 average target implies a +36% move from current prices. That is up +22% on the projected 2028 average. Momentum favours further upside here.
The RMTI price prediction for 2030 points to an average of $1.08 (low $0.8136, high $1.55) — a potential gain of +42% on today's $0.7641. Buyers look set to stay in control over this stretch.
In 2031, RMTI is projected to trade between $0.8538 and $1.69, averaging $1.16 — a potential gain of +51% from today's $0.7641. That is up +7% on the projected 2030 average. Momentum favours further upside here.
Rockwell Medical, Inc.'s 2032 outlook centres on $1.15, within a $0.8352 to $1.71 range. That is -1% versus the projected 2031 average. That marks a +50% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, RMTI could reach as high as $1.71, with a base case around $1.13 and support toward $0.8117 — roughly +48% from $0.7641. Momentum favours further upside here.
Expect RMTI to range from $0.9032 to $1.96 through 2034. The $1.28 average target implies a +67% move from current prices. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The RMTI price prediction for 2035 points to an average of $1.38 (low $0.9601, high $2.14) — a potential gain of +80% on today's $0.7641. Momentum favours further upside here.
In 2040, RMTI is projected to trade between $1.16 and $2.90, averaging $1.76 — a potential gain of +131% from today's $0.7641. That is up +28% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Rockwell Medical, Inc.'s 2050 outlook centres on $3.56, within a $2.11 to $6.37 range. That is up +102% on the projected 2040 average. That marks a +365% change versus current levels. Momentum favours further upside here.
Investing $1,000 in RMTI today (≈ 1,308.729224 RMTI) could be worth
$4,653.26
+$3,653.26 (+365%) by 2050 · US Dollar
Based on the average projected RMTI price of $3.56 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RMTIwould be worth at today's price.
$1,000 invested in RMTI on May 27, 2025 (≈ 1,041.66669 RMTI) would be worth
$795.94
-$204.06 (-20.4%) today · 0.80× · US Dollar
Based on a RMTI entry price of $0.96 vs. today's $0.7641.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.82 | $931.83 | -6.8% |
| 1 month ago | $0.85 | $898.94 | -10.1% |
| 3 months ago | $0.93 | $821.61 | -17.8% |
| 6 months ago | $1 | $764.1 | -23.6% |
| 1 year ago | $0.96 | $795.94 | -20.4% |
| All time (5.0y) ago | $10.01 | $76.33 | -92.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RMTI forecast.
Our base-case forecast reaches $1.50 around 2040.
Implied market cap at $1.50: $59.21M
The multi-year forecast develops a clear upside trajectory after a flat near-term start. The 2026 average is $0.7931, followed by a 2027 average of $0.8015 and a 2028 average of $0.9022, all with Neutral sentiment and rising expectations.
From 2029 onward the outlook turns bullish: 2029 average $1.10 with ROI 38.6, 2030 average $1.15 with ROI 45.1, 2031 average $1.23 with ROI 54.6, 2032 average $1.22 with ROI 53.4, 2033 average $1.21 with ROI 52.5, 2034 average $1.37 with ROI 72.4, and 2035 average $1.48 with ROI 86.
The trend continues into 2040 with an average of $1.91 and ROI 140.5, and into 2050 with an average of $3.82 and ROI 382.2, all under bullish sentiment. These are estimates and carry uncertainty, but they indicate meaningful upside potential over the long term.
Tap a question to reveal the answer.
2030 avg: $1.15; min: $0.8613; max: $1.65; ROI: 45.1; sentiment: BULLISH.
Forecasts show a bullish trajectory from 2029 onward, with 2030 average $1.15 and 2050 average $3.82, ROI up to 382.2; however, these are estimates and not guarantees.
Yes. The 2029 forecast shows avg $1.10 with a max of $1.55, and 2030 shows avg $1.15 with a max of $1.65.
Current price is $0.7931 and market cap is $31.3M.
30-day range is $0.6708 to $0.9377 and annualized volatility is 50.
Rockwell Medical, Inc. Community Discussion
0Share your Rockwell Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.